Quantitative EEG Analysis of Executive Dysfunction in Parkinson Disease
Authors:
- Satoshi KameiSKSatoshi Kamei
- Akihiko MoritaAMAkihiko Morita
- Kan SerizawaKSKan Serizawa
- Tomohiko MizutaniTMTomohiko Mizutani
- Kaname HirayanagiKHKaname Hirayanagi
- 1 June 2010
- journal article
- Published by Wolters Kluwer Health in Journal Of Clinical Neurophysiology
- Vol. 27 (3) , 193-197
Abstract
Quantitative EEG evaluation in Parkinson disease (PD) reveals diffuse slowing. This is the first quantitative EEG evaluation of the differences between PD with and without executive dysfunction (ExD). The subjects were 32 PD patients without remarkable dementia. The lack of ischemic lesions was confirmed by magnetic resonance imaging. ExD was defined as <70 points on the age-controlled standardized score of the Behavioral Assessment of the Dysexecutive Syndrome. Absolute power was measured for four frequency bands from delta to beta. Electrodes were placed at frontal pole, frontal, central, parietal, occipital, and temporal locations. Spectral ratio was calculated as the sum of power values for alpha and beta waves divided by the sum of values for the slow waves. In multiple logistic regression analysis of each electrode location, the dependent variable was ExD or not, and the independent variables were spectral ratio, age, and Unified Parkinson Disease Rating Scale. The only significant predictor of ExD was spectral ratio at the frontal pole (P = 0.031) and frontal (P = 0.048) locations. PD with ExD exhibited an increase in slow wave activity and a decrease in alpha and fast wave activities in these locations. These findings indicated that the ExD in PD was caused by frontal dysfunction.Keywords
This publication has 37 references indexed in Scilit:
- Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's diseaseParkinsonism & Related Disorders, 2007
- Clinical diagnostic criteria for dementia associated with Parkinson's diseaseMovement Disorders, 2007
- Relationship between event-related potentials and frontal-subcortical dysfunction in Parkinson's diseaseParkinsonism & Related Disorders, 2006
- Lateralisation of striatal function: evidence from 18F-dopa PET in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2005
- Stages in the development of Parkinson’s disease-related pathologyCell and tissue research, 2004
- Dementia associated with Parkinson's diseaseThe Lancet Neurology, 2003
- Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PETBrain, 2002
- COGNITIVE IMPAIRMENT IN EARLY, UNTREATED PARKINSON'S DISEASE AND ITS RELATIONSHIP TO MOTOR DISABILITYBrain, 1991
- Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: Evidence for a specific attentional dysfunctionNeuropsychologia, 1989
- MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal agingAmerican Journal of Roentgenology, 1987